168 related articles for article (PubMed ID: 18771004)
1. Development and characterization of bicalutamide-poloxamer F68 solid dispersion systems.
Sancheti PP; Vyas VM; Shah M; Karekar P; Pore YV
Pharmazie; 2008 Aug; 63(8):571-5. PubMed ID: 18771004
[TBL] [Abstract][Full Text] [Related]
2. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
Patil AL; Pore YV; Kuchekar BS; Late SG
Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
[TBL] [Abstract][Full Text] [Related]
3. Enhanced dissolution of solid dispersions containing bicalutamide subjected to mechanical stress.
Szafraniec J; Antosik A; Knapik-Kowalczuk J; Chmiel K; Kurek M; Gawlak K; Paluch M; Jachowicz R
Int J Pharm; 2018 May; 542(1-2):18-26. PubMed ID: 29481948
[TBL] [Abstract][Full Text] [Related]
4. Formation of bicalutamide nanodispersion for dissolution rate enhancement.
Li C; Li C; Le Y; Chen JF
Int J Pharm; 2011 Feb; 404(1-2):257-63. PubMed ID: 21093558
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical characterization of solid dispersion systems of tadalafil with poloxamer 407.
Vyas V; Sancheti P; Karekar P; Shah M; Pore Y
Acta Pharm; 2009 Dec; 59(4):453-61. PubMed ID: 19919934
[TBL] [Abstract][Full Text] [Related]
6. Nanosized bicalutamide and its molecular structure in solvents.
Le Y; Ji H; Chen JF; Shen Z; Yun J; Pu M
Int J Pharm; 2009 Mar; 370(1-2):175-80. PubMed ID: 19101616
[TBL] [Abstract][Full Text] [Related]
7. Preparation and physicochemical characterization of surfactant based solid dispersions of ezetimibe.
Sancheti PP; Karekar P; Vyas VM; Shah M; Pore YV
Pharmazie; 2009 Apr; 64(4):227-31. PubMed ID: 19435139
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical investigation of the solid dispersion systems of etoricoxib with poloxamer 188.
Karekar P; Vyas V; Shah M; Sancheti P; Pore Y
Pharm Dev Technol; 2009; 14(4):373-9. PubMed ID: 19552551
[TBL] [Abstract][Full Text] [Related]
9. Liquid antisolvent precipitation process for solubility modulation of bicalutamide.
Meer TA; Sawant KP; Amin PD
Acta Pharm; 2011 Dec; 61(4):435-45. PubMed ID: 22202202
[TBL] [Abstract][Full Text] [Related]
10. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers.
Ahuja N; Katare OP; Singh B
Eur J Pharm Biopharm; 2007 Jan; 65(1):26-38. PubMed ID: 16962750
[TBL] [Abstract][Full Text] [Related]
11. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407.
Newa M; Bhandari KH; Oh DH; Kim YR; Sung JH; Kim JO; Woo JS; Choi HG; Yong CS
Arch Pharm Res; 2008 Nov; 31(11):1497-507. PubMed ID: 19023548
[TBL] [Abstract][Full Text] [Related]
12. Planetary ball milling and supercritical fluid technology as a way to enhance dissolution of bicalutamide.
Szafraniec J; Antosik A; Knapik-Kowalczuk J; Kurek M; Syrek K; Chmiel K; Paluch M; Jachowicz R
Int J Pharm; 2017 Nov; 533(2):470-479. PubMed ID: 28363855
[TBL] [Abstract][Full Text] [Related]
13. Co-crystallization for enhanced dissolution rate of bicalutamide: preparation and evaluation of rapidly disintegrating tablets.
Essa EA; Elbasuony AR; Abdelaziz AE; El Maghraby GM
Drug Dev Ind Pharm; 2019 Aug; 45(8):1215-1223. PubMed ID: 30661420
[No Abstract] [Full Text] [Related]
14. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
15. In sight into tadalafil - block copolymer binary solid dispersion: Mechanistic investigation of dissolution enhancement.
Mehanna MM; Motawaa AM; Samaha MW
Int J Pharm; 2010 Dec; 402(1-2):78-88. PubMed ID: 20933589
[TBL] [Abstract][Full Text] [Related]
16. Monitoring the Dissolution Mechanisms of Amorphous Bicalutamide Solid Dispersions via Real-Time Raman Mapping.
Tres F; Patient JD; Williams PM; Treacher K; Booth J; Hughes LP; Wren SA; Aylott JW; Burley JC
Mol Pharm; 2015 May; 12(5):1512-22. PubMed ID: 25872658
[TBL] [Abstract][Full Text] [Related]
17. Preparation and physicochemical characterizations of tanshinone IIA solid dispersion.
Zhao X; Liu X; Gan L; Zhou C; Mo J
Arch Pharm Res; 2011 Jun; 34(6):949-59. PubMed ID: 21725816
[TBL] [Abstract][Full Text] [Related]
18. Dissolution behaviour of nalidixic acid solid dispersions using water soluble dispersion carriers.
Mallick S; Sahu A; Pal K
Acta Pol Pharm; 2004; 61(1):21-30. PubMed ID: 15259854
[TBL] [Abstract][Full Text] [Related]
19. Poloxamer 407 microspheres for orotransmucosal drug delivery. Part I: formulation, manufacturing and characterization.
Albertini B; Passerini N; Di Sabatino M; Monti D; Burgalassi S; Chetoni P; Rodriguez L
Int J Pharm; 2010 Oct; 399(1-2):71-9. PubMed ID: 20696227
[TBL] [Abstract][Full Text] [Related]
20. Tabletting solid dispersions of bicalutamide prepared using ball-milling or supercritical carbon dioxide: the interrelationship between phase transition and
Antosik-Rogóż A; Szafraniec-Szczęsny J; Gawlak K; Knapik-Kowalczuk J; Paluch M; Jachowicz R
Pharm Dev Technol; 2020 Nov; 25(9):1109-1117. PubMed ID: 32686538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
